Laboratory tests indicated the biotech’s shot would still protect against virus variants detected in the U.K. and South Africa, although the latter appeared to result in a weaker immune response.
Show CommentsClose Comments
Laboratory tests indicated the biotech’s shot would still protect against virus variants detected in the U.K. and South Africa, although the latter appeared to result in a weaker immune response.